RYZNEUTA — EVIVE BIOTECHNOLOGY, approved 2023-11-16 (BLA761134).
52 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.